GNOM ETF

$53.90

Returns Overview

1 Month
-5.64%
3 Months
+20.25%
6 Months
+12.13%
YTD
+18.15%
1 Year
+70.44%
3 Years (annualized)
+5.88%
5 Years (annualized)
-10.38%

Risk Metrics (1-Year)

No risk data available for this ETF

Stress Test Scenarios

How would GNOM have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
🔒Upgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
🔒Upgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
🔒Upgrade to run

1 Month Performance

-5.64%

3 Months Performance

+20.25%

6 Months Performance

+12.13%

1 Year Performance

+70.44%

Benchmark & Peers

Benchmark
Solactive Genomics Index(^SOLAGI)
This ETF (YTD)
+18.15%
Peer Avg (YTD)
+7.57%
vs Peers
+10.58%

GNOM ETF Performance

GNOM performance across multiple time periods: 1-month -5.64%, YTD 18.15%, 1-year 70.44%, 3-year 5.88%, 5-year -10.38%.

GNOM returns outperform the peer average of 7.57% YTD. With an expense ratio of 0.50%, investors should weigh costs against performance when evaluating this ETF.

GNOM performance comparison shows side-by-side returns with another fund. GNOM alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month-5.64%Jun 29, 2026 to Jul 28, 2026
3 Months+20.25%Apr 28, 2026 to Jul 28, 2026
6 Months+12.13%Jan 28, 2026 to Jul 28, 2026
1 Year+70.44%N/A
3 Years+5.88%N/A
5 Years-10.38%N/A

Periods up to 1 year are total returns; 3, 5 and 10 year figures are annualized